ArticleJournal for immunotherapy of cancer2020

Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.